ITAC
LIVE

Serial Number

98808648

Owner

Heidelberg Pharma Research GmbH

Attorney

Norman P. Soloway

Filing Date

Oct 18, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ITAC Trademark

Serial Number: 98808648

ITAC is a trademark filed by Heidelberg Pharma Research GmbH on October 18, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Heidelberg Pharma Research GmbH (3 trademarks)

Gregor-Mendel Straße 22
Ladenburg 68526 , DE

Entity Type: 99

Trademark Details

Filing Date

October 18, 2024

Registration Date

Not Registered

Goods & Services

Pharmaceutical research services; Medical and pharmacological research services; Pharmaceutical product development; Development of pharmaceutical preparations and medicines; Consultancy relating to pharmaceutical research and development; Provision of research services in the field of toxicology, stem cell and medical research; Scientific research; Medical research; Biomedical research services; Research relating to biotechnology; Research on the subject of pharmaceuticals; Consultancy relating to research in the field of pharmacogenetics; Research and development in the pharmaceutical and biotechnology fields; Research and development in the field of diagnostic preparations; Research and development in the field of biotechnology; Research and development for the pharmaceutical industry; Research and development services in the field of antibody technology; Research and development services in the field of antibodies and antibody-drug conjugates; Laboratory services relating to the production of monoclonal antibodies and antibody-drug conjugates

Pharmaceutical services, namely, pharmaceutical compounding services in the field of oncology; Pharmaceutical advice; Pharmaceutical services, namely, pharmaceutical compounding services; Consultancy and information services relating to pharmaceutical products; Providing healthcare information regarding cancer drugs and cancer treatment

Pharmaceutical preparations for the treatment of cancer; Pharmaceuticals for the treatment of cancer; Chemicopharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations for veterinary use for the treatment of cancer; Chemical preparations for pharmaceutical purposes for the treatment of cancer; Pharmaceutical preparations for human use for the treatment of cancer; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for use in oncology; Diagnostic preparations for medical purposes; Diagnostic agents for pharmaceutical use; Diagnostic agents for medical use; Diagnostic preparations for veterinary purposes; Clinical diagnostic reagents; Diagnostic chemical reagents for medical use; Anticancer drugs; Compounds for treating cancer; Anti-cancer preparations; Anti-cancer preparations of chemical origin; Biopharmaceuticals for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer; Chemotherapeutics; Antibodies for medical purposes; Antibody-drug conjugates for the treatment of cancer; Pharmaceutical preparations for immunotherapy

Filing History

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 18, 2026 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 17, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 17, 2025 GNSL
SUSPENSION LETTER WRITTEN
Jul 17, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 3, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 3, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 3, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 24, 2025 GNRN
NON-FINAL ACTION E-MAILED
Apr 24, 2025 GNRT
NON-FINAL ACTION WRITTEN
Apr 24, 2025 CNRT
ASSIGNED TO EXAMINER
Apr 22, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 21, 2025 NWOS
NEW APPLICATION ENTERED
Oct 18, 2024 NWAP